<html><head><title>Last Compo EcoR1 Capital, LLC</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>EcoR1 Capital, LLC<br>#assets : 67<br>AUMs(M$) : 1,860</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>name</th>
      <th>mktcap</th>
      <th>sector</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
    <tr>
      <th>ticker</th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>XNCR US</th>
      <td>XENCOR INC</td>
      <td>2396.62</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>10.6</td>
      <td>XENCOR INC</td>
      <td>30September20</td>
      <td>12.5</td>
      <td>-1.9</td>
    </tr>
    <tr>
      <th>RLAY US</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>3400.53</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">7.1</div></td>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>9.7</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.6</div></td>
    </tr>
    <tr>
      <th>STTK US</th>
      <td>SHATTUCK LABS INC</td>
      <td>1518.57</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">6.9</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">6.9</div></td>
    </tr>
    <tr>
      <th>SBTX US</th>
      <td>SILVERBACK THERAPEUTICS INC</td>
      <td>1369.66</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">6.3</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">6.3</div></td>
    </tr>
    <tr>
      <th>PRTA US</th>
      <td>PROTHENA CORP PLC</td>
      <td>757.94</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>6.0</td>
      <td>PROTHENA CORP PLC</td>
      <td>30September20</td>
      <td>6.7</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>ORIC US</th>
      <td>ORIC PHARMACEUTICALS INC</td>
      <td>985.20</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>5.6</td>
      <td>ORIC PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>4.7</td>
      <td>0.9</td>
    </tr>
    <tr>
      <th>MRTX US</th>
      <td>MIRATI THERAPEUTICS INC</td>
      <td>8613.18</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>5.4</td>
      <td>MIRATI THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>5.4</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>MORF US</th>
      <td>MORPHIC HLDG INC</td>
      <td>946.55</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>5.1</td>
      <td>MORPHIC HLDG INC</td>
      <td>30September20</td>
      <td>5.5</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>ANAB US</th>
      <td>ANAPTYSBIO INC</td>
      <td>722.82</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>3.7</td>
      <td>ANAPTYSBIO INC</td>
      <td>30September20</td>
      <td>3.3</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>BIIB US</th>
      <td>BIOGEN INC</td>
      <td>35364.69</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">3.3</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.3</div></td>
    </tr>
    <tr>
      <th>SLDB US</th>
      <td>SOLID BIOSCIENCES INC</td>
      <td>359.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">3.2</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.2</div></td>
    </tr>
    <tr>
      <th>KURA US</th>
      <td>KURA ONCOLOGY INC</td>
      <td>1856.23</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">3.1</div></td>
      <td>KURA ONCOLOGY INC</td>
      <td>30September20</td>
      <td>10.0</td>
      <td><div p style="color:black;background:#f5d2ce;">-6.9</div></td>
    </tr>
    <tr>
      <th>RCUS US</th>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>1866.36</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>3.0</td>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>0.8</td>
    </tr>
    <tr>
      <th>RNA US</th>
      <td>AVIDITY BIOSCIENCES INC</td>
      <td>712.94</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.8</td>
      <td>AVIDITY BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>4.2</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>67080M103</th>
      <td>NURIX THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>2.7</td>
      <td>NURIX THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.9</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>NLTX US</th>
      <td>NEOLEUKIN THERAPEUTICS INC</td>
      <td>447.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.3</td>
      <td>NEOLEUKIN THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>3.3</td>
      <td>-1.0</td>
    </tr>
    <tr>
      <th>04965G109</th>
      <td>ATRECA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>2.1</td>
      <td>ATRECA INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>00973J101</th>
      <td>AKOUOS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>2.1</td>
      <td>AKOUOS INC</td>
      <td>30September20</td>
      <td>3.2</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>03824M109</th>
      <td>APPLIED MOLECULAR TRANS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.9</td>
      <td>APPLIED MOLECULAR TRANS INC</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>GERN US</th>
      <td>GERON CORP</td>
      <td>480.75</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.6</td>
      <td>GERON CORP</td>
      <td>30September20</td>
      <td>2.3</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>38341PAA0</th>
      <td>GOSSAMER BIO INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>GOSSAMER BIO INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>16961L106</th>
      <td>CHINOOK THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>019818103</th>
      <td>ALLOVIR INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.9</td>
      <td>ALLOVIR INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>39868T105</th>
      <td>GRITSTONE ONCOLOGY INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>50107A104</th>
      <td>KRONOS BIO INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>ACIU US</th>
      <td>AC IMMUNE SA</td>
      <td>479.89</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>SYRS US</th>
      <td>SYROS PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>92731L106</th>
      <td>VINCERA PHARMA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>ACRS US</th>
      <td>ACLARIS THERAPEUTICS INC</td>
      <td>956.49</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>ACLARIS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>ALPN US</th>
      <td>ALPINE IMMUNE SCIENCES INC</td>
      <td>194.64</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>ALPINE IMMUNE SCIENCES INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>244413100</th>
      <td>DEERFIELD HEALTHCARE TECH AC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>ITOS US</th>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>1082.98</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>KYMR US</th>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>2318.22</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>54142F102</th>
      <td>LOGICBIO THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>12529R107</th>
      <td>C4 THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>15678U128</th>
      <td>CEREVEL THERAPEUTICS HLDNG I</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>G4411D109</th>
      <td>HEALTH SCIENCES ACQ CORP 2 ORD</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>HEALTH SCIENCES ACQ CORP 2</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>CYCN US</th>
      <td>CYCLERION THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>CYCLERION THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>698102209</th>
      <td>PANACEA ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>PANACEA ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>47760M102</th>
      <td>JIYA ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>192010106</th>
      <td>CODIAK BIOSCIENCES INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>26818M108</th>
      <td>DYNE THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>DYNE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>62921N105</th>
      <td>NGM BIOPHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>GLPG US</th>
      <td>GALAPAGOS NV</td>
      <td>4671.47</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>G4444C102</th>
      <td>HELIX ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>38341P102</th>
      <td>GOSSAMER BIO INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G3710A121</th>
      <td>FRAZIER LIFESCIENCES ACQU CO</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G3141W114</th>
      <td>EUCRATES BIOMEDICAL ACQU COR</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G2445M129</th>
      <td>CONSONANCE HFW ACQUISITION C</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G0904B105</th>
      <td>BCLS ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>92731L114</th>
      <td>VINCERA PHARMA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>53229E103</th>
      <td>LIFESCI ACQUISITION II CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>STRO US</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>721.60</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">0.1</div></td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.1</div></td>
    </tr>
    <tr>
      <th>59101E103</th>
      <td>METACRINE INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>METACRINE INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>33836P105</th>
      <td>5 01 ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>69353Y103</th>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>09077B104</th>
      <td>BIOATLA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>ASMB US</th>
      <td>ASSEMBLY BIOSCIENCES INC</td>
      <td>168.81</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">0.0</div></td>
      <td>ASSEMBLY BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.9</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.9</div></td>
    </tr>
    <tr>
      <th>SURF US</th>
      <td>SURFACE ONCOLOGY INC</td>
      <td>287.73</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>SURFACE ONCOLOGY INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>-1.6</td>
    </tr>
    <tr>
      <th>KNTE US</th>
      <td>KINNATE BIOPHARMA INC</td>
      <td>1258.06</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>RPTX US</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>1032.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G59665102</th>
      <td>MEIRAGTX HLDGS PLC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>MEIRAGTX HLDGS PLC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>ICPT US</th>
      <td>INTERCEPT PHARMACEUTICALS IN</td>
      <td>845.18</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>INTERCEPT PHARMACEUTICALS IN</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>G9127T116</th>
      <td>TURMERIC ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>244413118</th>
      <td>DEERFIELD HEALTHCARE TECH AC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>38000Q102</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>GLYCOMIMETICS INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>53228P109</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>LIFESCI ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>210373106</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>CONSTELLATION PHARMCETICLS I</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>46333X108</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>IRONWOOD PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>244413209</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>DEERFIELD HEALTHCARE TECH AC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>303020101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>FS DEV CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>33830X104</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>30205M101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>EXICURE INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G7709Q104</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>ROYALTY PHARMA PLC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>805111101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>SAVARA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>91381U101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>UNITY BIOTECHNOLOGY INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>98419J206</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>XOMA CORP DEL</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.